MINT-VENLAFAXINE XR
MINT PHARMACEUTICALS INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MINT-VENLAFAXINE XR in Canada?
Yes. MINT-VENLAFAXINE XR 150MG has an active shortage reported to Health Canada (last updated October 27, 2026).
Why is MINT-VENLAFAXINE XR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MINT-VENLAFAXINE XR be available again?
The manufacturer's estimated resolution date is January 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
EFFEXOR XR
Extended-ReleaseBGP PHARMA ULC
TARO-VENLAFAXINE XR
Extended-ReleaseSUN PHARMA CANADA INC
M-VENLAFAXINE XR
Extended-ReleaseMANTRA PHARMA INC
VENLAFAXINE XR
Extended-ReleaseSIVEM PHARMACEUTICALS ULC
AURO-VENLAFAXINE XR
Extended-ReleaseAURO PHARMA INC
APO-DESVENLAFAXINE
APOTEX INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02522993
Strength
150MG
Dosage Form
CAPSULE (EXTENDED RELEASE)
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Requirements related to complying with good manufacturing practices.
Disruption of the manufacture of the drug.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
10MG · DIN 02468840
25MG · DIN 02468859
200MG · DIN 02524708
400MG · DIN 02524716
800MG · DIN 02524724
70.0MG · DIN 02394871
5MG · DIN 02362651
10MG · DIN 02362678
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430